HR021618

· Jiangsu HengRui Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HR021618, covering 2021-08-06 to 2025-05-15. Get the full timeline:

Most recent: Clinical Trial Update: HR021618 in Moderate to Severe Pain After Abdominal Surgery [Phase 2]